NEW YORK, March 2, 2006 (PRIMEZONE) -- Harbinger Research LLC (www.harbingerresearch.com), an independent research firm, issued an investment profile today for Pacific Biometrics, Inc. (OTCBB:PBME), a provider of specialty and central laboratory services along with theranostics diagnostic technologies that support pharmaceutical and diagnostic healthcare companies.
The report provides an in-depth summary and overview of the company as an investment opportunity, an overview of its businesses, the sales and marketing strategy, including a historical industry background.
The report is available free of charge at http://www.harbingerresearch.com.
About Harbinger Research, LLC
Harbinger Research is a quality-leading independent research company that provides insightful, in-depth equity research coverage to smaller U.S.-traded companies and the individuals and institutions that invest in them.
For further information on Harbinger Research, please visit www.harbingerresearch.com.
About Pacific Biometrics
Pacific Biometrics, Inc. (OTCBB:PBME) is a holding company that conducts its business through its two subsidiaries: Pacific Biometrics, Inc. and PBI Technology, Inc. Pacific Biometrics (the subsidiary) provides specialty reference and central laboratory services as well as contract research services that support pharmaceutical and diagnostic manufacturers conducting human clinical trial research for use in drug and diagnostic product development. The company's specialty reference laboratory, located in Seattle, Washington, provides specialized services in the following three core areas of expertise: (1) cardiovascular diseases -- dyslipidemia, atherosclerosis, and coronary heart disease; (2) diabetes and obesity; and (3) bone and joint diseases -- osteoporosis as well as osteo and rheumatoid arthritis. Pacific Biometrics' services are utilized primarily by the pharmaceutical, biotechnology and laboratory diagnostic industries.
Statement under the Private Securities Litigation Reform Act
With the exception of the historical information contained in this release, the matters described herein contain forward-looking statements that involve risk and uncertainties that may individually or mutually impact the matters herein described, including but not limited to the ability of the company to increase revenues in the future due to the developing and unpredictable markets for its products, the ability to achieve a positive cash flow, the ability to obtain orders for or install its products, the ability to obtain new customers and the ability to continue to commercialize its products, which could cause actual results or revenues to differ materially from those contemplated by these statements.
Harbinger Research, LLC received US$5,200 from the company in return for report authoring and distribution services.